Cooled radiofrequency ablation versus standard medical management for chronic sacroiliac joint pain : a multicenter, randomized comparative effectiveness study

© American Society of Regional Anesthesia & Pain Medicine 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ..

INTRODUCTION: Low back pain is the leading cause of disability worldwide, with sacroiliac joint pain comprising up to 30% of cases of axial lower back pain. Conservative therapies provide only modest relief. Although placebo-controlled trials show efficacy for sacral lateral branch cooled radiofrequency ablation, there are no comparative effectiveness studies.

METHODS: In this randomized, multicenter comparative effectiveness study, 210 patients with clinically suspected sacroiliac joint pain who obtained short-term benefit from diagnostic sacroiliac joint injections and prognostic lateral branch blocks were randomly assigned to receive cooled radiofrequency ablation of the L5 dorsal ramus and S1-S3 lateral branches or standard medical management consisting of pharmacotherapy, injections and integrative therapies. The primary outcome measure was mean reduction in low back pain score on a 0-10 Numeric Rating Scale at 3 months. Secondary outcomes included measures of quality of life and function.

RESULTS: 3 months post-treatment, the mean Numeric Rating Scale pain score for the cooled radiofrequency ablation group was 3.8±2.4 (mean reduction 2.5±2.5) compared with 5.9±1.7 (mean reduction 0.4±1.7) in the standard medical management group (p<0.0001). 52.3% of subjects in the cooled radiofrequency ablation group experienced >2 points or 30% pain relief and were deemed responders versus 4.3% of standard medical management patients (p<0.0001). Comparable improvements favoring cooled radiofrequency ablation were noted in Oswestry Disability Index score (mean 29.7±15.2 vs 41.5+13.6; p<0.0001) and quality of life (mean EuroQoL-5 score 0.68±0.22 vs 0.47±0.29; p<0.0001).

CONCLUSIONS: In patients with sacroiliac joint pain, cooled radiofrequency ablation provided statistically superior improvements across the spectrum of patient outcomes compared with standard medical management.

TRIAL REGISTRATION NUMBER: NCT03601949.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:49

Enthalten in:

Regional anesthesia and pain medicine - 49(2024), 3 vom: 04. März, Seite 184-191

Sprache:

Englisch

Beteiligte Personen:

Cohen, Steven P [VerfasserIn]
Kapural, Leonardo [VerfasserIn]
Kohan, Lynn [VerfasserIn]
Li, Sean [VerfasserIn]
Hurley, Robert W [VerfasserIn]
Vallejo, Richard [VerfasserIn]
Eshraghi, Yashar [VerfasserIn]
Dinakar, Pradeep [VerfasserIn]
Durbhakula, Shravani [VerfasserIn]
Beall, Douglas P [VerfasserIn]
Desai, Mehul J [VerfasserIn]
Reece, David [VerfasserIn]
Christiansen, Sandy [VerfasserIn]
Chang, Min Ho [VerfasserIn]
Carinci, Adam J [VerfasserIn]
DePalma, Michael [VerfasserIn]

Links:

Volltext

Themen:

Anesthesia, Local
Back Pain
CHRONIC PAIN
Journal Article
Multicenter Study
Pain Management
Randomized Controlled Trial

Anmerkungen:

Date Completed 06.03.2024

Date Revised 24.03.2024

published: Electronic

ClinicalTrials.gov: NCT03601949

Citation Status MEDLINE

doi:

10.1136/rapm-2023-104568

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM359084281